These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 10462449
1. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities. Gorlatov SN, Stadtman TC. Arch Biochem Biophys; 1999 Sep 01; 369(1):133-42. PubMed ID: 10462449 [Abstract] [Full Text] [Related]
2. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG. Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2521-6. PubMed ID: 10688911 [Abstract] [Full Text] [Related]
3. Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Gorlatov SN, Stadtman TC. Proc Natl Acad Sci U S A; 1998 Jul 21; 95(15):8520-5. PubMed ID: 9671710 [Abstract] [Full Text] [Related]
4. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney. Crosley LK, Méplan C, Nicol F, Rundlöf AK, Arnér ES, Hesketh JE, Arthur JR. Arch Biochem Biophys; 2007 Mar 15; 459(2):178-88. PubMed ID: 17291446 [Abstract] [Full Text] [Related]
5. Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells. Liu SY, Stadtman TC. Proc Natl Acad Sci U S A; 1997 Jun 10; 94(12):6138-41. PubMed ID: 9177183 [Abstract] [Full Text] [Related]
6. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions. Du Y, Wu Y, Cao X, Cui W, Zhang H, Tian W, Ji M, Holmgren A, Zhong L. Biochimie; 2009 Mar 10; 91(3):434-44. PubMed ID: 19059456 [Abstract] [Full Text] [Related]
7. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Wang Y, Zhang H, Holmgren A, Tian W, Zhong L. Oncol Rep; 2008 Dec 10; 20(6):1479-87. PubMed ID: 19020731 [Abstract] [Full Text] [Related]
8. Monoclonal antibodies to human thioredoxin reductase. Söderberg A, Sahaf B, Holmgren A, Rosén A. Biochem Biophys Res Commun; 1998 Aug 10; 249(1):86-9. PubMed ID: 9705836 [Abstract] [Full Text] [Related]
9. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. Arnér ES, Sarioglu H, Lottspeich F, Holmgren A, Böck A. J Mol Biol; 1999 Oct 08; 292(5):1003-16. PubMed ID: 10512699 [Abstract] [Full Text] [Related]
10. Highly active dimeric and low-activity tetrameric forms of selenium-containing rat thioredoxin reductase 1. Rengby O, Cheng Q, Vahter M, Jörnvall H, Arnér ES. Free Radic Biol Med; 2009 Apr 01; 46(7):893-904. PubMed ID: 19146949 [Abstract] [Full Text] [Related]
11. The role of thioredoxin reductase activity in selenium-induced cytotoxicity. Madeja Z, Sroka J, Nyström C, Björkhem-Bergman L, Nordman T, Damdimopoulos A, Nalvarte I, Eriksson LC, Spyrou G, Olsson JM, Björnstedt M. Biochem Pharmacol; 2005 Jun 15; 69(12):1765-72. PubMed ID: 15935149 [Abstract] [Full Text] [Related]
12. Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling. Rigobello MP, Bindoli A. Methods Enzymol; 2010 Jun 15; 474():109-22. PubMed ID: 20609907 [Abstract] [Full Text] [Related]
13. Induction of apoptosis by the overexpression of an alternative splicing variant of mitochondrial thioredoxin reductase. Chang EY, Son SK, Ko HS, Baek SH, Kim JH, Kim JR. Free Radic Biol Med; 2005 Dec 15; 39(12):1666-75. PubMed ID: 16298692 [Abstract] [Full Text] [Related]
14. A 35 kDa NAD(P)H oxidase previously isolated from the archaeon Sulfolobus solfataricus is instead a thioredoxin reductase. Ruocco MR, Ruggiero A, Masullo L, Arcari P, Masullo M. Biochimie; 2004 Dec 15; 86(12):883-92. PubMed ID: 15667938 [Abstract] [Full Text] [Related]
15. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Tamura T, Stadtman TC. Proc Natl Acad Sci U S A; 1996 Feb 06; 93(3):1006-11. PubMed ID: 8577704 [Abstract] [Full Text] [Related]
16. Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity. Urig S, Lieske J, Fritz-Wolf K, Irmler A, Becker K. FEBS Lett; 2006 Jun 26; 580(15):3595-600. PubMed ID: 16750198 [Abstract] [Full Text] [Related]
17. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate. Zhang H, Cao D, Cui W, Ji M, Qian X, Zhong L. Free Radic Biol Med; 2010 Dec 15; 49(12):2010-8. PubMed ID: 20951799 [Abstract] [Full Text] [Related]
18. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Rackham O, Shearwood AM, Thyer R, McNamara E, Davies SM, Callus BA, Miranda-Vizuete A, Berners-Price SJ, Cheng Q, Arnér ES, Filipovska A. Free Radic Biol Med; 2011 Mar 15; 50(6):689-99. PubMed ID: 21172426 [Abstract] [Full Text] [Related]
19. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y, Folan M, Shaw M, Messer RL, Lockwood PE, Hobbs D, Bouillaguet S, Sano H, Lewis JB, Wataha JC. Toxicol In Vitro; 2006 Sep 15; 20(6):882-90. PubMed ID: 16510263 [Abstract] [Full Text] [Related]
20. A stable mixed disulfide between thioredoxin reductase and its substrate, thioredoxin: preparation and characterization. Wang PF, Veine DM, Ahn SH, Williams CH. Biochemistry; 1996 Apr 16; 35(15):4812-9. PubMed ID: 8664271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]